| CTRI Number |
CTRI/2024/06/069272 [Registered on: 20/06/2024] Trial Registered Prospectively |
| Last Modified On: |
30/07/2026 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Homeopathy |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
Premenstrual Syndrome (PMS) is common conditions affecting women. The symptoms associated with PMS can significantly impact a womans quality of life. aims to contribute to the role of homeopathy has effectiveness in the treatment of PMS. |
|
Scientific Title of Study
|
A randomized study for assessing the efficacy of individualized homoeopathic medicines prescribed in 50 millesimal potency and centesimal potency in treatment of patient with pre-menstrual syndrome (PMS) among age group 18 to 25 years |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Alpesh Jayswal |
| Designation |
Assistant Professor |
| Affiliation |
Parul Institute of Homoeopathy and Research Hospital |
| Address |
ROOM NO 303 Department of Organon of Medicine
Parul Institute of Homoeopathy and Research Hospital,
Parul University
At- Ishwarpura Post -Limda Waghodia Vadodara Gujarat 391760
Vadodara GUJARAT 391760 India |
| Phone |
9978231023 |
| Fax |
|
| Email |
alpeshjaiswal18@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Alpesh Shah |
| Designation |
Professor, Principal and Guide |
| Affiliation |
Pioneer Homoeopathic Medical College and Hospital |
| Address |
201,2nd Floor,
Pioneer Homoeopathic Medical College and Hospital
At and Post Sayajipura Ajwa Nimeta Road,
N.H.No 8 Ajwa,Vadodara 390019
Vadodara GUJARAT 390019 India |
| Phone |
9825487564 |
| Fax |
|
| Email |
vrajdev@hotmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Alpesh Jayswal |
| Designation |
Assistant Professor |
| Affiliation |
Parul Institute of Homoeopathy and Research Hospital |
| Address |
ROOM NO 303 Department of Organon of Medicine
Parul Institute of Homoeopathy and Research Hospital,
Parul University
At- Ishwarpura Post -Limda Waghodia Vadodara Gujarat 391760
Vadodara GUJARAT 391760 India |
| Phone |
9978231023 |
| Fax |
|
| Email |
alpesh.jaiswal18@gmail.com |
|
|
Source of Monetary or Material Support
|
| Parul Institute of Homoeopathy and Research Hospital, Parul University At- Ishwarpura Post -Limda Waghodia Vadodara Gujarat 391760 |
|
|
Primary Sponsor
|
| Name |
Dr Alpesh Jayswal |
| Address |
ROOM NO 303 Department of Organon of Medicine Parul Institute of Homoeopathy and Research Hospital, Parul University At- Ishwarpura Post -Limda Waghodia Vadodara Gujarat
Pincode 391760 |
| Type of Sponsor |
Other [Self] |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Alpesh Jayswal |
Parul Institute of Homoeopathy and Research Hospital |
101-E Obstetric and Gynecology
Vadodara GUJARAT |
9978231023
alpeshjaiswal18@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| Parul Institute of Homoeopathy and Research Hospital |
No Objection Certificate |
| Smt Malini Kishore Sanghvi Homoeopathic Medical College and Hospital Institutional Ethical Committee |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: N943||Premenstrual tension syndrome, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Comparator Agent |
Individualized Homeopathic Medicines For Example Platina, Pulsatilla, Magnesium Phos etc |
50 Millesimal Potency for example 0/1, 0/2 etc BD for 30 Days |
| Intervention |
Individualized Homeopathic Medicines For Example Platina, Pulsatilla, Magnesium Phos etc |
Individualized Homeopathic Medicines given in Centisimal Potency for example 30,200,1M BD For 30 Days |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
25.00 Year(s) |
| Gender |
Female |
| Details |
1 Cases suffering from PMS.
2 Age between 18 to 25 years
3 PMS Diagnosed cases with Pre-Menstrual syndrome Scale (PMSS) Score is 80 or above 80.
4 Willingness to Participate Participants who provide informed consent and are willing to comply with the study requirements, including attending scheduled visits and following the prescribed treatment regimen. |
|
| ExclusionCriteria |
| Details |
1 Married Women
2 Participants with Menstrual irregularities like Leucorrhoea, Dysmenorrhoea, Menorrhoea ,Metrorrhagea, PCOS
3 Medical Conditions Participants with severe medical conditions or comorbidities that may interfere with the assessment of PMS symptoms or pose a risk to their well-being.
4 Psychiatric Disorders Participants with severe psychiatric disorders, such as major depressive disorder or bipolar disorder, which may require alternative treatment approaches.
5 Hormonal Treatment Participants currently receiving or planning to initiate hormonal treatments specifically for PMS during the study period, as this may confound the evaluation of homoeopathic treatment efficacy.
6 Previous Homoeopathic Treatment Participants who have received homoeopathic treatment for PMS within a defined period (e.g 3 months) prior to the study initiation.
7 Allergy or Sensitivity Participants with known allergies or sensitivities to homoeopathic medicines or their components.
8 Substance abuse and/or dependence
9 Diagnosed or suspected cases of any malignancy
10 Patients taking Allopathic or any other systemic medicine |
|
|
Method of Generating Random Sequence
|
Adaptive randomization, such as minimization |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Efficacy of individualized Homoeopathic Medicine in patient of pre-menstrual syndrome (PMS) among age group 18 to 25 years. |
Study Duration 1 Year.
Follow up at every Month for 3 menstrual Cycle.
Intervention of Pre-Menstrual syndrome Scale (PMSS)at Every 3 months for assessing the score after giving individualized Homoeopathic Medicines in 50 millesimal and Centesimal Scale. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| 50 millesimal Potency and Centesimal Potency among this which Scale have more Significant improvement seen in treatment with Patient of pre-menstrual syndrome (PMS) among age group 18 to 25 years? |
1 Year |
| To listed potencies, which are more frequently used for Significant improvement seen in Patient of pre-menstrual syndrome (PMS) among age group 18 to 25 years of Centesimal Scale and 50 millesimal Scale. |
1 Year |
|
|
Target Sample Size
|
Total Sample Size="100" Sample Size from India="100"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 2/ Phase 3 |
|
Date of First Enrollment (India)
|
01/07/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
Recruitment Status of Trial (Global)
Modification(s)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Closed to Recruitment of Participants |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Premenstrual Syndrome (PMS) is common conditions affecting women during the luteal phase of their menstrual cycle. The symptoms associated with these conditions can significantly impact a woman’s quality of life.Conventional medical treatments for PMS often involve the use of hormonal therapies and antidepressants, but their efficacy and potential side effects have raised concerns among patients and healthcare providers. As a result, there is growing interest in alternative and complementary therapies, such as homeopathy.This study aims to assess the efficacy of individualized homeopathic medicines prescribed in 50 millesimal potency and centesimal potency in the treatment of patients with PMS. |